Trial Profile
A retrospective study evaluating efficacy of Lactobacillus Reuteri (Dsm 17938) in patients with functional constipation.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 May 2017
Price :
$35
*
At a glance
- Drugs Limosilactobacillus reuteri (Primary)
- Indications Constipation
- Focus Therapeutic Use
- 25 May 2017 New trial record
- 09 May 2017 Results presented at the Digestive Disease Week 2017